Cost-Utility Analysis of Add-On Qili Qiangxin Capsules in Chronic Heart Failure with Reduced Ejection Fraction in China
This cost-utility analysis suggested that adding QLQX capsules seems to be cost-effective of heart failure with a reduced ejection fraction patients from the healthcare payer's perspective in China. Future studies of QLQX capsules based on different economic systems and medical environments were also needed.
Authors
- Yinglin Wang (ORCID: https://orcid.org/0000-0003-0688-4989)
- Quan Zhao
- Lu Wang (ORCID: https://orcid.org/0000-0001-9833-7450)
Institutions
- Yuhuangding Hospital (CN)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1002/ehf2.15272
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39